Breast Cancer Clinical Trials in Kansas City, MO

Breast Cancer Clinical Trials in Kansas City, MO

View the best 10 breast cancer medical studies in Kansas City, Missouri. Access promising new therapies by applying to a Kansas City-based Breast Cancer clinical trial.

Trials in Kansas City, Missouri

Here are the top 10 medical studies for breast cancer in Kansas City, Missouri

Image of Northwest Georgia Oncology Centers in Marietta, United States.

Sacituzumab Govitecan-hziy

Monoclonal Antibodies

Recruiting2 awardsPhase 3
This trial will compare a new drug (SG) to current treatments for metastatic breast cancer to see if it can improve life spans. Primary objective is to compare its effect on progression-free survival (PFS).
Image of University of Alabama at Birmingham in Birmingham, United States.

Tucatinib +1 More

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial will see if tucatinib and T-DXd work better together than T-DXd alone to treat HER2+ breast cancer.
Image of Florida Cancer Specialists South - SCRI - PPDS in Sarasota, United States.

H3B-6545 +1 More

Protein Degrader

Recruiting1 awardPhase 1
This trial is testing a combination of two drugs to treat estrogen receptor-positive breast cancer. The goal is to find the maximum tolerated dose and/or the recommended Phase 2 dose of the combination.
Image of Banner MD Anderson Cancer Center in Gilbert, United States.

Breast surgery

Procedure

Recruiting2 awardsPhase 3
This trial is testing whether adding an MRI to the standard mammogram improves accuracy in diagnosing breast tumors before surgery.
Image of City of Hope Comprehensive Cancer Center in Duarte, United States.

Placebo +1 More

Chemoprevention

Recruiting1 awardPhase 3
This trial compares metformin to placebo to see if it can prevent breast cancer.
Image of University of Miami in Miami, United States.

Palbociclib +1 More

CDK4/6 Inhibitor

Recruiting1 awardPhase 2
This trial is testing if any of these combinations can help treat breast cancer.
Image of Mayo Clinic Hospital in Arizona in Phoenix, United States.

Atezolizumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 2
This trial is testing olaparib with or without atezolizumab to treat non-HER2-positive breast cancer that has spread and is not able to be surgically removed or has metastasized.
Image of CBCC Global Research Inc., at Comprehensive Blood and Cancer Center in Bakersfield, United States.

Endocrine Therapy of Physician's Choice +1 More

Hormone Therapy

Recruiting2 awardsPhase 3
This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Image of University of Alabama Birmingham in Birmingham, United States.

Standard Adjuvant Endocrine Therapy

Hormone Therapy

Recruiting2 awardsPhase 3
This trial is testing a new drug to see if it can effectively treat early stage breast cancer that is hormone receptor positive and human epidermal receptor 2 negative.
Image of Highlands Oncology Group in Fayetteville, United States.

Abemaciclib +1 More

CDK4/6 Inhibitor

Recruiting3 awardsPhase 3
This trial is comparing two treatments for hormone receptor positive, HER2 negative advanced breast cancer. One group will receive abemaciclib + fulvestrant, and the other will just receive fulvestrant. The study will last about 9 months for each participant.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.